Equasens (XPAR:EQS) ROCE % : 21.89% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Equasens ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Equasens's annualized ROCE % for the quarter that ended in Dec. 2023 was 21.89%.

Equasens ROCE % Historical Data

The historical data trend for Equasens's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens ROCE % Chart

Equasens Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

24.83

23.24

23.29

22.54

21.57

Equasens Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															21.06	25.30	21.95	21.89	-

Equasens ROCE % Calculation

Equasens's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	58.077	/	( ( (350.812 - 98.142)	+	(394.045 - 108.132) )	/ 2 )
	=	58.077	/	( (252.67	+	285.913)	/ 2 )
	=	58.077	/	269.2915
	=	21.57 %

Equasens's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	59.826	/	( ( (379.208 - 118.581)	+	(394.045 - 108.132) )	/ 2 )
	=	59.826	/	( ( 260.627	+	285.913 )	/ 2 )
	=	59.826	/	273.27
	=	21.89 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Equasens (XPAR:EQS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Equasens ROCE % Related Terms

Thank you for viewing the detailed overview of Equasens's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Equasens Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (XPAR:EQS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0R9T:UK PHF:Germany

Address

5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600

Website

https://www.equasens.com

Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.